Clinical Trial Update: Genetic Identification (ID) of Segmental Dysplastic Nevi

View source ↗

Summary

A clinical trial investigating genetic identification of segmental dysplastic nevus has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Segmental Dysplastic Nevus

Snippet

Sponsor: Nova Scotia Health Authority | Conditions: Segmental Dysplastic Nevi | Status: WITHDRAWN